Meningococcal Vaccines Market: Rising Disease Awareness and Growth in Marketing Authorizations to Drive the Market

Wilmington, Delaware, USA, Transparency Market Research Inc. – Meningococcal vaccines are used to prevent diseases such as meningitis, meningococcemia and sepsis caused by N. meningitidis. Meningococcal disease, particularly meningococcal meningitis, is highly contagious in individuals or communities.

Read the report overview – https://www.transparencymarketresearch.com/meningococcal-vaccines-market.html

Several meningococcal serogroups have been identified to date; among these, serogroups A, B, C, Y and W-135 are the most important in causing infection. The increasing prevalence of meningococcal meningitis has recently become a public health problem. Several treatment options for meningococcal infection are available worldwide; however, the disease still claimed several lives.

Meningococcal disease is transmitted by contact with secretions from the nose and throat (saliva or sputum). Kissing, sharing silverware, drinking from the same vessel, sharing a cigarette or lipstick, coughing, and having close social contact (living in the same house) are examples of how the disease spreads. Vaccination is one of the most effective ways to prevent meningococcal disease.

Request a sample report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1666

Meningococcal Vaccines Market Outlook 2031

  • The meningococcal vaccines market was valued at US$4.2 billion in 2021
  • It is estimated to grow at a CAGR of 9.4% from 2022 to 2031
  • The Meningococcal Vaccines Market is expected to reach a value of US$9.2 billion by the end of 2031

Rise in Meningitis Prevalence to Drive Global Meningococcal Vaccine Market

Meningococcal disease is uncommon; however, it has a mortality rate between 5% and 15%. If left untreated, it often leads to serious complications. Meningococcal meningitis causes an infection of the brain and spinal cord. It has the potential to cause large epidemics and endemics. Each year, approximately 10 to 15 of every 100 people infected with meningococcal disease die. One in five survivors is likely to suffer permanent disabilities such as deafness, brain damage, loss of a limb or seizures. Consequently, the demand for meningitis vaccines is increasing worldwide.

Custom Search Request – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1666

Increased Disease Awareness and Growth in Marketing Authorizations to Drive the Market

The National Meningitis Association (NMA) encourages collaboration by providing opportunities to work with government agencies, businesses, and other nonprofit organizations to raise awareness of meningococcal disease, its prevention, and the critical need for treatment. immediately after diagnosis. Increasing the coverage rate of immunization programs around the world is likely to increase access to vaccines. The Meningitis Foundation of America (MFA) is a nonprofit organization that provides information and support for people with meningitis. The foundation also aims to educate the public and doctors about the early symptoms of meningitis. Thus, the meningococcal vaccines market is expected to grow at a steady rate during the forecast period.

Rising Sales of Meningococcal Conjugate Vaccines in Developing Countries to Fuel the Market

By type, conjugate vaccines segment is expected to dominate the market and account for 62% share by 2031. The benefits of meningococcal conjugate vaccines such as long-lasting immunity, immunological memory, avidity and herd immunity, drive sales. This trend is expected to continue during the forecast period. Conjugate vaccines are widely used in mass vaccination campaigns in affected areas such as Africa. In addition, they have the ability to increase the persistence of antibodies. Various meningococcal conjugate vaccine programs have been introduced around the world over the past few decades. The vaccine has significantly reduced the incidence of meningococcal disease since 2010. The recently introduced serogroup C conjugate vaccine is safe and effective even in the youngest children. Group B meningococcal vaccines have shown modest efficacy in children and adults.

Ask for references – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=1666

Government support and high R&D investments are driving the market in North America

North America dominated the global meningococcal vaccines market in 2021. The region’s market is expected to grow at a notable CAGR from 2022 to 2031. Government recommendations and support and high R&D investments are driving the market in North America. The United States is expected to be an important market for meningococcal vaccines in North America due to increased awareness of the disease and improved healthcare infrastructure in the country. Meningococcal disease has been on the decline in the United States since the 1990s.

According to the Centers for Disease Control and Prevention (CDC), approximately 350 cases of meningococcal disease were reported in 2017. Additionally, awareness among the general public is increasing. The meningococcal vaccines market in Asia Pacific is expected to grow at a rapid rate owing to the presence of a large population, better access to healthcare systems and increased awareness of meningococcal disease in the region.

Inquire Before You Buy – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1666

Key Players Analysis of the Global Meningococcal Vaccines Market

The global meningococcal vaccines market is fragmented with a large number of large-scale vendors controlling the majority of the share. Most companies invest heavily in comprehensive research and development activities. Expansion of product portfolios and mergers and acquisitions are major strategies adopted by major players. Market players are focusing on key meningococcal vaccine trends with the help of recent R&D insights.

Sanofi SA, Novartis International, GlaxoSmithKline plc, Pfizer Inc., Nuron Biotech, JN-International Medical Corporation, Serum Institute of India Ltd., Baxter International and Biomed Pvt. ltd. are the main entities operating in the market. Each of these players has been profiled in the Meningococcal Vaccines Market report on the basis of parameters such as company overview, financial overview, business strategies, application portfolio, segments activity and recent developments.

More trending reports by Transparency Market Research –

Post Surgery Pain Therapies Market: The global market for postoperative pain treatments is expected to reach over US$22.3 billion by the end of 2031.

ACL Reconstruction Procedures Market: The ACL reconstruction procedures market is expected to mature from a revenue of US$6.8 billion in 2020 and reach US$11.5 billion by 2031.

CAR T Cell Therapy Market: The CAR T-cell therapy market is expected to register a CAGR of 30.6% during the assessment period.

Retinal Vein Occlusion Market: The retinal vein occlusion market is expected to exceed US$32.5 billion by 2031. The retinal vein occlusion market is expected to show a favorable CAGR of 7.3% during the forecast period.

Adrenocorticotropic Hormones Market: The adrenocorticotropic hormone (ACTH) market is expected to surpass US$1.91 billion by 2031.

veterinary supplements market: The veterinary supplements market is expected to reach US$13.76 billion by 2031. The veterinary supplements market is expected to grow at a CAGR of 6.5% during the forecast period.

Von Willebrand’s disease treatment market: The global von Willebrand disease treatment market is expected to reach a market value of approximately $900 million by the end of 2030.

Wound Irrigation Systems Market: Global revenues are expected to reach over US$419.1 million by 2031. Growing demand for wound care products in the elderly is propelling revenue streams; opportunities in the Asia-Pacific market to expand at a remarkable growth rate during the forecast period.

About Us

Transparency Market Research, a global market research company registered in Wilmington, Delaware, USA, provides personalized research and consulting services. Our proprietary blend of quantitative forecasting and trend analysis delivers forward-looking insights to thousands of decision makers. Our experienced team of analysts, researchers and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continually updated and reviewed by a team of research experts, so that it always reflects the latest trends and information. With broad research and analytical capability, Transparency Market Research uses rigorous primary and secondary research techniques to develop distinctive datasets and research material for trade reports.

For more information on research on leading industries, visit our YouTube channel and click subscribe for future update – https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
HEADQUARTERS IN THE CITY CENTER,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

Blog: https://tmrblog.com

E-mail: [email protected]